Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term nalbuphine analgesia in ICU patients
CTR20251339Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Aug 2025; status: completed.
02
Drugs
nalbuphine
03
Conditions
pain
Beyond the preview
Go deeper on CTR20251339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251339.